UPDATE: NovoCure Ltd. (NVCR) PT Raised to $235 at Piper Sandler Following Bull vs. Bear Debate (CORRECT)
Tweet Send to a Friend
(Updated - April 16, 2021 9:16 AM EDT)
Piper Sandler analyst Jason Bednar raised the price target on NovoCure ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Jason Bednar raised the price target on NovoCure ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
